| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Savara Inc | Director | Common Stock | 102,500 | $366,950 | $3.58 | 09 Dec 2025 | Direct |
| LUMOS PHARMA, INC. | Director | Common Stock | 0 | $0 | $1.89 | 12 Dec 2024 | Direct |
| PLUS THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 297,794 | 13 Aug 2025 | Direct | ||
| LUMOS PHARMA, INC. | Director | Stock Option (Right to Buy) | 0 | 12 Dec 2024 | Direct |